HEARTKINETICS
0728.461.387 · rovalta.com · 23/09/2026
HEARTKINETICS
Company — Opening of bankruptcy.
Overview
What does HEARTKINETICS do?
HEARTKINETICS is a Public limited company incorporated in 2019. Its main activity is: Research and experimental development on social sciences and humanities. Its registered office is in Charleroi.
6041 Charleroi · WallonieSee on map
Joint committees (1)
- 200
Trend over 3 financial years
| 2022 | 2021 | 2020 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | -463,7 k € | -10449% | -4,4 k € | +79.2% | -21,2 k € |
| EBITDA | -1 M € | -1040% | -90,2 k € | -312% | -21,9 k € |
| Operating result | -1,1 M € | -585% | -155,5 k € | -338% | -35,5 k € |
| Net result | -1 M € | -755% | -121,9 k € | -4782% | -2,5 k € |
| Balance sheet | |||||
| Equity | 1,8 M € | +24.8% | 1,4 M € | +474% | 248,8 k € |
| Total assets | 2,9 M € | +92.5% | 1,5 M € | +400% | 301,7 k € |
| Cash | 553 k € | -42.9% | 968,9 k € | +1263% | 71,1 k € |
| Debts | 1,1 M € | +1464% | 71,2 k € | +59.5% | 44,6 k € |
Board of directors
Seen on filing of 31/12/2022 · 6 active · 18 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
CANCER STATE THERAPEUTICS● Active | 0793.113.273 |
European Infrared Technologies● Active | 0643.646.468 |
Genflow Biosciences● Active | 0753.904.685 |
NEUVASQ BIOTECHNOLOGIES● Active | 0762.966.663 |
SYNABS● Active | 0637.716.206 |
T-knife Therapeutics● Active | 1037.005.620 |
Financials
Full financial information
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 13/06/2019 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 19 months |
| Filing date | 28/06/2023 | 24/05/2022 | 13/08/2021 |
| General meeting | 11/05/2023 | 12/05/2022 | 13/05/2021 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
3 filings with the NBB
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2022 · 6 active · 18 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Other19/01/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates17/10/2022DEMISSIONS, NOMINATIONS
- Mandates23/06/2022DEMISSIONS, NOMINATIONS - DIVERS
- Mandates31/12/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates26/07/2021DEMISSIONS, NOMINATIONS
- Mandates07/08/2020STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
- Other17/06/2019RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022-1 M €↓
- 2021Annual accounts 2021-121,9 k €↓
- 2020Annual accounts 2020-2,5 k €
- 13/06/2019IncorporationPublic limited company